Dr. Bishoy Morris Faltas is an Instructor in Medicine at Weill Cornell Medicine and an Assistant Attending in the Genitourinary Oncology Program in the Division of Hematology & Medical Oncology.
Dr. Faltas completed his Hematology and Medical Oncology Fellowship at Weill Cornell Medicine, as well as additional training through a one-year research fellowship in the laboratory of Dr. Mark A. Rubin. During this time, he led studies of the clonal evolution and the neoantigenic structure of platinum-resistant urothelial carcinoma.
As a physician-scientist, Dr. Faltas conducts research focusing on understanding the molecular profiles of metastatic platinum-resistant urothelial bladder carcinoma. His research focus is on the mechanisms of mutagenesis and drug-resistance in bladder carcinoma, as well as immunogenomic studies of urological malignancies. By understanding the molecular changes that occur as urothelial cancer evolves under the effect of chemotherapy and metastatic spread, Dr. Faltas aims to identify potential drug targets for translation into therapeutic clinical trials. He is an active member of the The Caryl and Israel Englander Institute for Precision Medicine focusing on the application of genomic approaches to clinical trials by tailoring treatment based on the unique molecular profile of each patient’s cancer.
Visit this webpage to learn more about Dr. Faltas and make an appointment.